Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia

Psychological Medicine

Volumn 40, Issue 6, 2010, Pages 935-944

  Gonzalez Blanch C ^a   Perez Iglesias, R ^a   Pardo Garcia G ^a   Rodriguez Snchez J M ^a   Martinez Garcia O ^a   Vazquez Barquero J L ^a   Crespo Facorro, B ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Cognitive deficits; First episode; Predictors; Recovery; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTENTION; COGNITIVE DEFECT; COHORT ANALYSIS; DISABILITY; DRUG EFFECT; FEMALE; HUMAN; INDEPENDENT LIVING; LONGITUDINAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PROGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SOCIAL ADAPTATION; SPAIN; VOCATIONAL REHABILITATION;

ADULT; ANTIPSYCHOTIC AGENTS; ATTENTION; COGNITION DISORDERS; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; INDEPENDENT LIVING; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REHABILITATION, VOCATIONAL; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; SPAIN; YOUNG ADULT;

EID: 77952359232     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291709991267     Document Type: Article

References (46)

1. Andreasen NC (1981). Scale for the Assessment of Negative Symptoms (SANS). University of Iowa: Iowa City, IA.
2. Andreasen NC (1983). Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa: Iowa City, IA.
3. Birchwood M, Todd P, Jackson C (1998). Early intervention in psychosis. The critical period hypothesis. The British Journal of Psychiatry 172, 53-59. (Pubitemid 28258899)
4. Bowie CR, Leung WW, Reichenberg A, McClure MM, Patterson TL, Heaton RK, Harvey PD (2008). Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biological Psychiatry 63, 505-511.
5. Bowie CR, Reichenberg A, Patterson TL, Heaton RK, Harvey PD (2006). Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. American Journal of Psychiatry 163, 418-425.
6. Cannon-Spoor HE, Potkin SG, Wyatt RJ (1982). Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin 8, 470-484.
7. Carpenter Jr. WT, Strauss JS (1991). The prediction of outcome in schizophrenia. IV: eleven-year follow-up of the Washington IPSS cohort. Journal of Nervous and Mental Disease 179, 517-525.
8. Cegalis J, Bowlin J (1991). Vigil: Software for the Assessment of Attention. Forthought: Nashua, NH.
9. Crespo-Facorro B, Perez-Iglesias R, Ramirez-Bonilla M, Martinez-Garcia O, Llorca J, Vazquez-Barquero JL (2006). A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. Journal of Clinical Psychiatry 67, 1511-1521.
10. Dickerson F, Boronow JJ, Ringel N, Parente F (1999). Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up. Schizophrenia Research 37, 13-20.
11. Fenton WS, McGlashan TH (1987). Prognostic scale for chronic schizophrenia. Schizophrenia Bulletin 13, 277-286.
12. First MB, Spitzer RL, Gibbon M, Williams JBW (1995). Structured Clinical Interview for DSM-IV Axis I Disorders. Biometrics Research Department, New York State Psychiatric Institute: New York.
13. Gaite L, Vazquez-Barquero JL, Herran A, Thornicroft G, Becker T, Sierra-Biddle D, Ruggeri M, Schene A, Knapp M, Vazquez-Bourgon J (2005). Main determinants of Global Assessment of Functioning score in schizophrenia: a European multicenter study. Comprehensive Psychiatry 46, 440-446.
14. Gleeson JF, Cotton SM, Alvarez-Jimenez M, Wade D, Gee D, Crisp K, Pearce T, Newman B, Spiliotacopoulos D, Castle D, McGorry PD (2009). A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. Journal of Clinical Psychiatry 70, 477-486.
15. González-Blanch C, Crespo-Facorro B, Alvarez-Jiménez M, Rodr?́guez-Sanchez JM, Pelayo-Terán JM, Pérez-Iglesias R, Vázquez-Barquero JL (2007). Cognitive dimensions in first-episode schizophrenia spectrum disorders. Journal of Psychiatric Research 41, 968-977.
16. Gonzalez-Blanch C, Crespo-Facorro B, Alvarez-Jimenez M, Rodriguez-Sanchez JM, Pelayo-Teran JM, Perez-Iglesias R, Vazquez-Barquero JL (2008). Pretreatment predictors of cognitive deficits in early psychosis. Psychological Medicine 38, 737-746.
17. Green MF (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry 153, 321-330.
18. Green MF, Kern RS, Braff DL, Mintz J (2000). Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the 'right stuff'? Schizophrenia Bulletin 26, 119-136.
19. Green MF, Kern RS, Heaton RK (2004). Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research 72, 41-51.
20. Grube BS, Bilder RM, Goldman RS (1998). Meta-analysis of symptom factors in schizophrenia. Schizophrenia Research 31, 113-120.
21. Gumley A, O'Grady M, McNay L, Reilly J, Power K, Norrie J (2003). Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine 33, 419-431.
22. Harrow M, Sands JR, Silverstein ML, Goldberg JF (1997). Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study. Schizophrenia Bulletin 23, 287-303.
23. Hofer A, Baumgartner S, Bodner T, Edlinger M, Hummer M, Kemmler G, Rettenbacher MA, Fleischhacker WW (2005). Patient outcomes in schizophrenia II: the impact of cognition. European Psychiatry 20, 395-402.
24. Holthausen EA, Wiersma D, Cahn W, Kahn RS, Dingemans PM, Schene AH, van den Bosch RJ (2007). Predictive value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Research 149, 71-80.
25. Johnstone EC, Macmillan JF, Frith CD, Benn DK, Crow TJ (1990). Further investigation of the predictors of outcome following first schizophrenic episodes. British Journal of Psychiatry 157, 182-189.
26. Keefe RS, Poe M, Walker TM, Harvey PD (2006). The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome. Journal of Clinical and Experimental Neuropsychology 28, 260-269. (Pubitemid 43254518)
27. Killackey E, Jackson HJ, McGorry PD (2008). Vocational intervention in first-episode psychosis: individual placement and support v. treatment as usual. British Journal of Psychiatry 193, 114-120.
28. Lasalvia A, Bonetto C, Cristofalo D, Tansella M, Ruggeri M (2007). Predicting clinical and social outcome of patients attending 'real world' mental health services: a 6-year multi-wave follow-up study. Acta Psychiatrica Scandinavica 437 (Suppl.), S16-S30.
29. Lezak MD, Howieson DB, Loring W (2004). Neuropsychological Assessment. Oxford University Press: New York.
30. Mañá S, Ivorra J, Girón M (1998). Adaptación y fiabilidad de la entrevista para la evaluación de la discapacidad social en pacientes psiquiátricos (OMS). Revista de Psiquiatŕ?a de la Facultad de Medicina de Barcelona 25, 43-48.
31. Menezes NM, Arenovich T, Zipursky RB (2006). A systematic review of longitudinal outcome studies of first-episode psychosis. Psychological Medicine 36, 1349-1362.
32. Milev P, Ho BC, Arndt S, Andreasen NC (2005). Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry 162, 495-506.
33. Miller IW, Bishop S, Norman WH, Maddever H (1985). The Modified Hamilton Rating Scale for Depression: reliability and validity. Psychiatry Research 14, 131-142.
34. Norman RM, Malla AK, Cortese L, Cheng S, Diaz K, McIntosh E, McLean TS, Rickwood A, Voruganti LP (1999). Symptoms and cognition as predictors of community functioning: a prospective analysis. American Journal of Psychiatry 156, 400-405.
35. Revheim N, Schechter I, Kim D, Silipo G, Allingham B, Butler P, Javitt DC (2006). Neurocognitive and symptom correlates of daily problem-solving skills in schizophrenia. Schizophrenia Research 83, 237-245.
36. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM (2004). Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. American Journal of Psychiatry 161, 473-479.
37. Schretlen D, Bobholz J, Brandt J (1996). Development and psychometric properties of the Brief Test of Attention. Clinical Neuropsychologist 10, 80-89.
38. Spreen O, Strauss E (1998). A Compendium of Neuropsychological Test: Administration, Norms, and Commentary. Oxford University Press: New York.
39. Swartz MS, Perkins DO, Stroup TS, Davis SM, Capuano G, Rosenheck RA, Reimherr F, McGee MF, Keefe RS, McEvoy JP, Hsiao JK, Lieberman JA (2007). Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. American Journal of Psychiatry 164, 428-436. (Pubitemid 46513156)
40. Twamley EW, Doshi RR, Nayak GV, Palmer BW, Golshan S, Heaton RK, Patterson TL, Jeste DV (2002). Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. American Journal of Psychiatry 159, 2013-2020.
41. van Winkel R, Myin-Germeys I, de Hert M, Delespaul P, Peuskens J, van Os J (2007). The association between cognition and functional outcome in first-episode patients with schizophrenia: mystery resolved? Acta Psychiatrica Scandinavica 116, 119-124.
42. Velligan DI, Mahurin RK, Diamond PL, Hazleton BC, Eckert SL, Miller AL (1997). The functional significance of symptomatology and cognitive function in schizophrenia. Schizophrenia Research 25, 21-31.
43. Verdoux H, Liraud F, Assens F, Abalan F, van Os J (2002). Social and clinical consequences of cognitive deficits in early psychosis: a two-year follow-up study of first-admitted patients. Schizophrenia Research 56, 149-159.
44. Wechsler D (1999). Wechsler Adult Intelligence Scale-III. TEA Ediciones: Madrid.
45. Zarate Jr. CA, Tohen M, Land ML (2000). First-episode schizophreniform disorder: comparisons with first-episode schizophrenia. Schizophrenia Research 46, 31-34.
46. Zhang M, Wang M, Li J, Phillips MR (1994). Randomised-control trial of family intervention for 78 first-episode male schizophrenic patients. An 18-month study in Suzhou, Jiangsu. British Journal of Psychiatry 24 (Suppl.), S96-S102.